Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Corbus Pharma (CRBP)

$4.61 0.16 (3.35%)

12:18 EST CRBP Stock Quote Delayed 15 Minutes

Volume:

Previous Close $4.77

Market Cap 263.43M

PE Ratio -6.59

EPS -0.7

Volume (Avg. Vol.) 275,683

Day's Range 4.51 - 4.80

52-Week Range 4.18 - 9.11

Dividend & Yield N/A (N/A)

CRBP Stock Predictions, Articles, and Corbus Pharma News

From InvestorPlace
From the Web

5 Marijuana Stocks to Stay Far Away From

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Oct 4, 2018

Although marijuana stocks are all the rage right now, there are some I wouldn't touch with a 10-foot pole. Here are pot stocks that investors should avoid.

Interesting CRBP Put And Call Options For July 2020

From Market News Video Nov 19, 2019

Investors in Corbus Pharmaceuticals Holdings Inc (CRBP) saw new options begin trading this week, for the July 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Corbus Pharma completes patient enrollment in mid-stage lenabasum study for CF

From Seeking Alpha Nov 18, 2019

Corbus Pharmaceuticals (NASDAQ:CRBP) has completed patient enrollment in the Phase 2b study evaluating the efficacy and safety of lenabasum for the treatment of cystic fibrosis (CF).Topline d

The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher

From Benzinga Nov 13, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals...

The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict

From Benzinga Nov 10, 2019

After the previous week's strong gains, biotech stocks experienced a slight loss of momentum this week. The week saw a few clinical trial readouts and a slew of earnings ...

Oversold Conditions For Corbus Pharmaceuticals Holdings (CRBP)

From Market News Video Nov 8, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Stocks That Hit 52-Week Lows On Friday

From Benzinga Nov 8, 2019

On Friday morning, 148 companies hit new 52-week lows. Points of Interest: Occidental Petroleum (NYSE: OXY) was the biggest company by market cap to set a new 52-week low. Geovax...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!